China's top court applies safe harbor, rejects hub-and-spoke claims in drug dispute
By MLex Staff ( October 29, 2026, 07:53 GMT | Insight) -- China's top court has applied antitrust safe-harbor rules to resale-price restrictions in pharmaceutical distribution agreements, while rejecting allegations that a drugmaker organized a hub-and-spoke cartel among its distributors. The ruling illustrates the judicial application of safe-harbor thresholds issued by the State Administration for Market Regulation last December and effective Feb. 1. The thresholds give concrete conditions for the safe harbor introduced in the 2022 amendments to the Antimonopoly Law.China's top court has applied antitrust safe-harbor rules to resale-price restrictions in pharmaceutical distribution agreements, while rejecting allegations that a drugmaker organized a hub-and-spoke cartel among its distributors....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.